Fidelity Disruptive Medicine ETF company info

What does Fidelity Disruptive Medicine ETF do?
Fidelity Disruptive Medicine ETF (NASDAQ:FMED) focuses on healthcare innovation, investing in companies that redefine or accelerate the medical industry through technology and groundbreaking approaches. This ETF targets firms across various stages of product development, from initial research to commercialization, emphasizing areas like biotechnology, pharmaceuticals, life sciences, and healthcare equipment. Fidelity Disruptive Medicine ETF aims to provide investors with exposure to potentially high-growth opportunities within the disruptive healthcare sector, demonstrating a commitment to capturing the value generated by innovative medical solutions and advancements.
Fidelity Disruptive Medicine ETF company media
Company Snapshot

Is Fidelity Disruptive Medicine ETF a public or private company?

key
Ownership
Public

How many people does Fidelity Disruptive Medicine ETF employ?

people
Employees
75,996

What sector is Fidelity Disruptive Medicine ETF in?

pie chart
Sector
ETF

Where is the head office for Fidelity Disruptive Medicine ETF?

location pin
Head Office
Boston, United States

What year was Fidelity Disruptive Medicine ETF founded?

founded flag
Year Founded
2020
What does Fidelity Disruptive Medicine ETF specialise in?
/Healthcare Innovation /Investment Services /Advancing Medicine /Pharmaceutical Research /Biotechnology Sector /Emerging Therapies

What are the products and/or services of Fidelity Disruptive Medicine ETF?

Overview of Fidelity Disruptive Medicine ETF offerings
Focused investment in innovative healthcare companies.
Explores advancements in genomics and biotechnology.
Captures transformation in digital health and telemedicine services.
Invests in breakthrough medical devices.
Targets companies revolutionizing patient diagnostics.
Supports firms developing personalized and precision medicine.